PP131 Omalizumab And Ciclosporin For Chronic Spontaneous Urticaria
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462319002484
Abstract: Introduction Omalizumab and ciclosporin are recommended in international clinical guidelines for treating antihistamine-resistant chronic spontaneous urticaria (CSU). This meta-analysis aimed to evaluate their comparative efficacy and safety to inform local treatment practices in Singapore. Methods… read more here.
Keywords: omalizumab ciclosporin; placebo; chronic spontaneous; ciclosporin ... See more keywords